Please try another search
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer’s disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson’s disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer’s disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.
Name | Age | Since | Title |
---|---|---|---|
Thomas P. Monath | 83 | 2022 | Member of Science Advisory Board |
Louis Garfield Reese | 42 | 2014 | Co-Founder & Executive Chairman of the Board |
Peter H. Diamandis | 63 | 2021 | Non-Employee Independent Director |
Stephen Nicholls | - | 2023 | Member of Scientific Advisory Board |
George Ronald Hornig | 70 | 2022 | Independent Director |
Richard Mohs | - | - | Member of Scientific Advisory Board |
Jeffrey L. Cummings | 74 | - | Member of Scientific Advisory Board |
Landon Ogilvie | 46 | 2023 | Lead Independent Director |
Frederick Raal | - | 2023 | Member of Scientific Advisory Board |
Kausik K. Ray | - | 2023 | Member of Scientific Advisory Board |
Stanley A. Plotkin | 91 | - | Member of Scientific Advisory Board |
Dirk Von Lewinski | - | 2023 | Member of Scientific Advisory Board |
Eric M. Reiman | - | - | Member of Scientific Advisory Board |
Nick Fox | - | - | Member of Scientific Advisory Board |
Wayne C. Koff | - | - | Member of Scientific Advisory Board |
James Alan Smith | 43 | 2023 | Independent Director |
Gabrielle B. Toledano | 57 | 2023 | Independent Director |
Parviz Ghahramani | - | 2023 | Member of Scientific Advisory Board |
Stephen D. Silberstein | - | 2023 | Member of Scientific Advisory Board |
Brad Boeve | - | - | Member of Scientific Advisory Board |
Thomas Fleming | - | 2023 | Member of Scientific Advisory Board |
Mei Mei Hu | 41 | 2014 | Co-Founder, President, CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review